Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alprostadil as Additional Anticoagulant in Veno-Venous ECMO
NCT02895373Phase 2Terminated
- Start
- Jul 2016
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Vasostenoon in acute respiratory distress syndrome (ARDS). Started Jul 2016; status: terminated.
02
Drugs
Vasostenoon
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT02895373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02895373.